Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers

✍ Scribed by Masakazu Nakamura; Akira Oshima; Yoko Fujimoto; Nami Maruyama; Taro Ishibashi; Karen R. Reeves

• Book ID: 116371995
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 244 KB
• Volume: 29
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2007.06.012